Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
hypertensive252 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A36710 | 17410441 | Dig Dis Sci | Telmisartan, an angiotensin II type 1 receptor blocker, controls progress of nonalcoholic steatohepatitis in rats. | 2007 | Details |
| A36711 | 17410287 | J Gastrointestin Liver Dis | Therapeutic options in non-alcoholic steatohepatitis (NASH). Are all agents alike? Results of a preliminary study. | 2007 | Details |
| A36990 | 16768123 | Nihon Rinsho | [Drug therapy for non-alcoholic steatohepatitis]. | 2006 | Details |
| A37472 | 15605307 | Semin Liver Dis | Hepatotoxicity of drugs used for treatment of obesity and its comorbidities. | 2004 | Details |
| A42409 | 34616249 | Case Rep Gastroenterol | Upper GI Bleeding Secondary to Radiation Gastritis in a Patient with Preexisting Portal Hypertensive Gastropathy. | 2021 | Details |
| A42433 | 34532001 | Food Sci Nutr | L-citrulline inhibits body weight gain and hepatic fat accumulation by improving lipid metabolism in a rat nonalcoholic fatty liver disease model. | 2021 | Details |
| A42478 | 34432677 | Eur J Gastroenterol Hepatol | Differences between sporadic hyperplastic gastric polyps and portal hypertensive gastric polyps: a review. | 2022 | Details |
| A42690 | 33759592 | Angiology | AST to ALT Ratio and Peripheral Arterial Disease in a Hypertensive Population-Is There a Link? | 2021 | Details |
| A42836 | 33337742 | Clin Obstet Gynecol | Polycystic Ovarian Syndrome: Impact on Adult and Fetal Health. | 2021 | Details |
| A43904 | 30498606 | Case Rep Gastrointest Med | Gastrointestinal Bleeding Secondary to Portal Hypertensive Duodenopathy in a Patient with Decompensated Liver Cirrhosis. | 2018 | Details |
| A44517 | 28386270 | PPAR Res | Fimasartan Ameliorates Nonalcoholic Fatty Liver Disease through PPARδ Regulation in Hyperlipidemic and Hypertensive Conditions. | 2017 | Details |
| A45612 | 23672630 | Curr Med Res Opin | Cardiovascular risk reduction with combination of anti-atherosclerotic medications in younger and older patients. | 2013 | Details |
| A46372 | 19246643 | Am J Pathol | Oxidative stress-mediated mitochondrial dysfunction contributes to angiotensin II-induced nonalcoholic fatty liver disease in transgenic Ren2 rats. | 2009 | Details |
| A46475 | 18385424 | J Am Soc Nephrol | Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease. | 2008 | Details |
| A46618 | 17267845 | Obstet Gynecol | Management of obesity in pregnancy. | 2007 | Details |
| A46692 | 16489319 | Panminerva Med | Insulin resistance, the insulin resistance syndrome, and cardiovascular disease. | 2005 | Details |
| A46788 | 15547646 | Angiology | Prevention and treatment of the metabolic syndrome. | 2005 | Details |
| A46808 | 15151470 | Expert Rev Cardiovasc Ther | Treatment of metabolic syndrome. | 2004 | Details |
| A47840 | 31094175 | Ter Arkh | Risk factors associated with portal vein thrombosis in liver cirrhosis: A case-control study. | 2019 | Details |
| A47872 | 30515332 | Int J Hepatol | Video Capsule Endoscopy in the Assessment of Portal Hypertensive Enteropathy. | 2018 | Details |
| A48285 | 17369113 | Dig Liver Dis | Essential hypertension and chronic viral hepatitis. | 2007 | Details |
| A48403 | 12364344 | Hypertension | Obesity hypertension in children: a problem of epidemic proportions. | 2002 | Details |
| A48523 | 34904513 | Scand J Gastroenterol | The relationship between portal hypertension and portal hypertensive gastropathy. | 2021 | Details |
| A48899 | 25230385 | Rozhl Chir | Bariatric metabolic surgery. | 2014 | Details |
| A49217 | 35819592 | Pharmacol Rep | Suppression of nitric oxide synthase aggravates non-alcoholic steatohepatitis and atherosclerosis in SHRSP5/Dmcr rat via acceleration of abnormal lipid metabolism. | 2022 | Details |
| A49459 | 35744831 | Molecules | Expatiating the Pharmacological and Nanotechnological Aspects of the Alkaloidal Drug Berberine: Current and Future Trends. | 2022 | Details |
| A49552 | 35717780 | Biomed Pharmacother | Postbiotics as potential new therapeutic agents for metabolic disorders management. | 2022 | Details |
| A49586 | 35702844 | J Assoc Physicians India | A Study on FibroScan and Endoscopic Finding in Patients of Chronic Liver Disease attending Tripura Medical College and Dr. B.R. Ambedkar Memorial Teaching Hospital. | 2022 | Details |
| A49683 | 35672152 | Pharm Biol | Camel milk protein hydrosylate alleviates hepatic steatosis and hypertension in high fructose-fed rats. | 2022 | Details |
| A50117 | 35516713 | J Family Med Prim Care | Evaluation of lipoprotein (a) [Lp(a)] and lipid abnormalities in patients with newly detected hypertension and its association with severity of hypertension. | 2022 | Details |
| A50365 | 35416741 | Scand J Clin Lab Invest | Nonalcoholic fatty liver disease and its prognosis associates with shorter leucocyte telomeres in a 21-year follow-up study. | 2022 | Details |
| A50380 | 35411023 | J Hum Hypertens | Association between hypertension and nonalcoholic fatty liver disease: a cross-sectional and meta-analysis study. | 2022 | Details |
| A50528 | 35352692 | Eur J Gastroenterol Hepatol | The association between Dietary Diversity Score and odds of nonalcoholic fatty liver disease: a case-control study. | 2022 | Details |
| A50603 | 35328352 | Int J Mol Sci | Beneficial Effects of Dietary Nitrite on a Model of Nonalcoholic Steatohepatitis Induced by High-Fat/High-Cholesterol Diets in SHRSP5/Dmcr Rats: A Preliminary Study. | 2022 | Details |
| A50699 | 35295895 | Visc Med | Metabolic Surgery: Paradigm Shift in Metabolic Syndrome/Diabetes Therapy. | 2022 | Details |
| A50749 | 35278680 | Ann Hepatol | Trends in drug prescriptions for type 2 diabetes, hypertension, and dyslipidemia among adults with non-alcoholic fatty liver disease. | 2022 | Details |
| A50817 | 35194872 | J Intern Med | Uncontrolled hypertension: A neglected risk in patients with NAFLD. | 2022 | Details |
| A51520 | 35668935 | Front Pharmacol | Croton urucurana Baill. Ameliorates Metabolic Associated Fatty Liver Disease in Rats. | 2022 | Details |
| A52083 | 31557503 | Biochimie | Protocatechuic acid exhibits hepatoprotective, vasculoprotective, antioxidant and insulin-like effects in dexamethasone-induced insulin-resistant rats. | 2019 | Details |
| A52215 | 30032428 | Diabetologia | A novel dual PPAR-γ agonist/sEH inhibitor treats diabetic complications in a rat model of type 2 diabetes. | 2018 | Details |
| A52429 | 27209494 | Environ Health Prev Med | Importance of detoxifying enzymes in differentiating fibrotic development between SHRSP5/Dmcr and SHRSP rats. | 2016 | Details |
| A52640 | 24307792 | World J Gastroenterol | Splanchnic-aortic inflammatory axis in experimental portal hypertension. | 2013 | Details |
| A52854 | 20649581 | Br J Pharmacol | Irbesartan treatment up-regulates hepatic expression of PPARalpha and its target genes in obese Koletsky (fa(k)/fa(k)) rats: a link to amelioration of hypertriglyceridaemia. | 2010 | Details |
| A52913 | 19631025 | Br J Nutr | Experimental rat models to study the metabolic syndrome. | 2009 | Details |
| A52938 | 19275651 | Curr Pharm Des | Renal protective effect of metabolic therapy in patients with coronary artery disease and diabetes: from bench to bed side. | 2009 | Details |
| A53000 | 17999758 | Theor Biol Med Model | Inflammation: a way to understanding the evolution of portal hypertension. | 2007 | Details |
| A53035 | 16877964 | J Hypertens | Irbesartan restores the in-vivo insulin signaling pathway leading to Akt activation in obese Zucker rats. | 2006 | Details |
| A53068 | 15809359 | Hypertension | A new transgenic rat model of hepatic steatosis and the metabolic syndrome. | 2005 | Details |
| A53075 | 15589689 | Biochimie | Effects of streptozotocin and dietary fructose on delta-6 desaturation in spontaneously hypertensive rat liver. | 2004 | Details |
| A53139 | 10842668 | Ann N Y Acad Sci | Molecular pathology in the obese spontaneous hypertensive Koletsky rat: a model of syndrome X. | 1999 | Details |
| A53147 | 10321453 | Blood Press Suppl | Anti-hyperglycemic activity of moxonidine: metabolic and molecular effects in obese spontaneously hypertensive rats. | 1998 | Details |
| A53191 | 861167 | Br J Exp Pathol | Alloxan diabetes in spontaneously hypertensive rats: gravimetric, metabolic and histopathological alterations. | 1977 | Details |